Eric Lefebvre

Eric Lefebvre currently works at Fonds D Investissement De La Culture Et Des Communications, LP, as Board of Director, The CIHR Canadian HIV Trials Network, as Member, and Canadian Association For HIV Research, as Member.
Dr. Lefebvre also formerly worked at GlaxoSmithKline, Inc., as Director-Medical Affairs from 2001 to 2003, CymaBay Therapeutics, Inc., as Independent Director from 2022 to 2024, Janssen Pharmaceuticals, Inc., as Head-Global Medical Affairs from 2003 to 2007, Tobira Therapeutics, Inc., as Chief Medical Officer, Allergan UC, as Vice President-Research & Development from 2016 to 2018, GlaxoSmithKline Pharmaceuticals SA (Belgium), as Principal, Tobira Therapeutics, Inc., as Chief Medical Officer from 2012 to 2016, and Pliant Therapeutics, Inc., as Chief Medical Officer from 2018 to 2025.
Dr. Lefebvre received his doctorate degree from the University of Montréal and undergraduate degree from College d'Enseignement General et Prof.
Edouard-Montpetit.